Echocardiographic pattern of left ventricular function recovery in tachycardia-induced cardiomyopathy patients
Teodor Serban1,2, Jeanne du Fay de Lavallaz1,2, Diego Mannhart1,2
1Department of Cardiology, University Hospital Basel, Basel, Switzerland.
Insights
Tachycardia-induced cardiomyopathy (TCM) patients show persistent cardiac remodeling and worse functional recovery compared to other cardiomyopathies. Echocardiographic markers can help identify TCM, which is often underdiagnosed.
Area of Science:
- Cardiology
- Cardiovascular Diseases
- Cardiac Imaging
Background:
- Tachycardia-induced cardiomyopathy (TCM) is a partially reversible condition often underdiagnosed.
- Cardiac chamber remodeling in TCM is not fully understood.
- This study compares TCM with other cardiomyopathies (CM).
Purpose of the Study:
- To explore differences in left ventricle dimensions and functional recovery in TCM patients versus other CM.
- To identify predictors for TCM diagnosis.
Main Methods:
- Retrospective analysis of 238 patients with reduced ejection fraction and/or atrial fibrillation.
- Patients divided into TCM and control groups.
- Echocardiographic parameters including LVEDVI, fractional shortening, and LAVI were analyzed.
Main Results:
- TCM patients showed no significant improvement in indexed left ventricular end-diastolic volume (LVEDVI) post-treatment.
- TCM patients had worse baseline fractional shortening and higher baseline/follow-up indexed left atrial volume (LAVI).
- Predictors for TCM included normal LVEDVI, fractional shortening <30%, LAVI >40 mL/m², and normal left ventricle wall thickness.
Conclusions:
- TCM patients exhibit distinct functional recovery patterns with persistent left atrial and ventricular remodeling.
- Echocardiographic parameters may aid in pre-treatment TCM identification.
- TCM is associated with a higher incidence of persistent heart failure symptoms.
Aims:
Tachycardia-induced cardiomyopathy (TCM) represents a partially reversible type of cardiomyopathy (CM) that is often underdiagnosed and cardiac chamber remodelling in TCM remains incompletely understood. We aim to explore differences in the dimensions of the left ventricle and functional recovery in patients with TCM compared with patients with other forms of CM.
Methods And Results:
We identified patients with reduced ejection fraction (≤50%) and/or atrial fibrillation or flutter with a left ventricular ejection fraction that improved from baseline (≥15% in left ventricular ejection fraction at follow-up or normalization of cardiac function with at least 10% improvement). Patients were then divided into two groups: (A) TCM patients and (B) patients with other forms of CM (controls). Two hundred thirty-eight patients were included (31% female, 70 years median age), 127 patients had TCM, and 111 had other forms of CM. Patients with TCM did not significantly improve indexed left ventricular volume (LVEDVI) after treatment (60 [45, 84] mL/m2 versus 56 [45, 70] mL/m2 , P = ns) compared with controls (67 [54, 81] mL/m2 versus 52 [42, 69] mL/m2 , P < 0.001). Patients with TCM patients had significantly worse fractional shortening at baseline than controls (15.5 [12, 23] vs. 20 [13, 30], P = 0.01) and higher indexed left atrial volume (LAVI) at baseline than controls (48 [37, 58] vs. 41 [33, 51], P = 0.01) that remained dilated at follow-up (follow-up LAVI 41 [33, 52] mL/m2 ). Good predictors of TCM were: normal LVEDVI (LVEDVI < 58 mL/m2 (M) and < 52 mL/m2 (F)) (odds ratio [OR] 5.2; 95% confidence interval [CI] 2.2-13.3, P < 0.001), fractional shortening < 30% (OR 3.5; 95% CI 1.4-9.2, P = 0.009), LAVI >40 mL/m2 (OR 3.4; 95% CI 1.6-7.3, P = 0.001) and normal wall thickness left ventricle (OR 3.2; 95% CI 1.4-7.8, P = 0.008). 54% of patients with TCM demonstrated diastolic dysfunction at follow-up, without differences from controls (54% vs. 43%, P = ns). 21% of patients with TCM showed persistent heart failure symptoms at follow-up compared with 4.5% of controls, P = 0.004.
Conclusions:
TCM patients have a specific pattern of functional recovery with persistent remodelling of the left atria and left ventricle. Several echocardiographic parameters might help identify TCM before treatment.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology


